Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
01/2006
01/05/2006CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
01/05/2006CA2571356A1 Novel hexafluoroisopropanol derivatives
01/05/2006CA2571012A1 Tricyclic compounds and their use as mglur1 antagonists
01/04/2006EP1611091A1 Novel compounds
01/04/2006EP1611090A2 Cannabinoid receptor ligands
01/04/2006EP1611088A2 Hydroxamates as therapeutic agents
01/04/2006EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
01/04/2006CN1717388A Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation
01/04/2006CN1717376A Catalytic hydrogeneration of carbon-heteroatom double bonds
01/03/2006US6982279 Arylated furan- and thiophenecarboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
01/03/2006US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
01/03/2006CA2247451C Carboxylic acid derivatives having fused rings as retinoic acid receptor agonist
01/03/2006CA2244695C Cyclic amic acid derivatives
01/03/2006CA2093577C Alkyl or alkoxy substituted s-heterocyclic retinoids
12/2005
12/29/2005WO2005123722A1 Heterocyclic carboxamides with microbiocidal activity
12/29/2005WO2005123634A1 Fluorene derivative and organic electroluminescent device using same
12/29/2005WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
12/29/2005WO2005123065A1 Chemokine receptor antagonistic medicinal composition
12/29/2005WO2005009104A3 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
12/29/2005US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides
12/29/2005US20050288324 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
12/28/2005EP1609785A1 C-glycoside derivatives and salts thereof
12/28/2005EP1608638A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
12/28/2005EP1608637A1 Trifluoromethyl-thiophene carboxylic acid anilides and use thereof as fungicides
12/28/2005EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases
12/28/2005EP1608309A2 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
12/28/2005EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods
12/28/2005EP1399416A4 Peptide deformylase inhibitors
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP1084125B1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005CN1714076A Novel aryl ureido benzoic acid derivatives and their use
12/28/2005CN1714074A Process for producing aromatic nitrile compound
12/28/2005CN1233646C Process of 2-methyl-thiophene benzodinitro heterotropilidene
12/28/2005CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/27/2005CA2237910C Excitatory amino acid derivatives
12/27/2005CA2160712C Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
12/22/2005WO2005122278A1 Organic semiconductor thin film, organic semiconductor device, organic thin film transistor, and organic electro-luminescence element
12/22/2005WO2005122277A1 Organic thin film transistor
12/22/2005WO2005121134A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121120A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
12/22/2005WO2005121119A1 Hydroxamates, their manufacture and use as pharmaceutical agents
12/22/2005WO2005121063A1 Process for forming branched composition catalytically by carbon-hydrogen bond activation in a saturated moiety
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005066151A3 Histone deacetylase inhibitors
12/22/2005WO2005061443A3 Benzoyl-substituted phenylalanine amides
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282899 Resorcinol derivatives
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282821 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
12/22/2005DE102004027332A1 New organometallic transition metal compound useful as catalyst constituents of catalyst systems for the polymerization of ethylene
12/22/2005CA2569623A1 Novel compounds and use of tetrahydropyridothiophenes
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005CA2566525A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005CA2566515A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
12/22/2005CA2566512A1 Hydroxamates, their manufacture and use as pharmaceutical agents
12/21/2005EP1606275A1 Opioid receptor antagonists
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005CN1711252A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1709889A Compound having thio furan and acetylene ethylene bond, its preparation and use
12/21/2005CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
12/21/2005CN1232505C Substituted sulfamide (thio) carbonyl compounds
12/20/2005US6977265 Piperidine CCR-3 receptor antagonists
12/20/2005CA2273303C Thienylsulfonylamino(thio)carbonyl compounds
12/20/2005CA2181569C Ep2-receptor agonists as agents for lowering intraocular pressure
12/15/2005WO2005119315A2 Non-linear optically active molecules, their synthesis, and use
12/15/2005WO2005118654A1 Transition metal compound, ligand system, catalyst system and process for preparing polyolefins
12/15/2005WO2005117907A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/15/2005WO2005117590A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/15/2005US20050277665 e.g. 1,1,1-trifluoro-2-[4-(toluene-2-sulfonyl)phenyl]-propan-2-ol; hydroxysteroid dehydrogenases inhibitor; interconversion between cortisone and cortisol in humans; antidiabetic agent; obesity, insulin resistance, non-insulin -dependent diabetes
12/15/2005US20050276754 Bridged aromatic substituted amine ligands with donor atoms
12/15/2005US20050274954 Organic thin film transistor
12/15/2005CA2568639A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/15/2005CA2565705A1 Non-linear optically active molecules, their synthesis, and use
12/14/2005EP1605733A1 Conjugate molecule, electroluminescent element using the same and electronic apparatus using the electroluminescent element
12/14/2005EP1603914A1 Compounds having activity at 5ht2c receptor and uses thereof
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1066258B1 Aryl phenyl substituted cyclic ketoenols
12/14/2005CN1708496A Cyclopropyl-thienyl-carboxamide as fungicides
12/14/2005CN1708479A Novel compounds useful in treating PPAR mediated diseases
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1706839A Non-benzenoid aryl spiro material and its synthesis and application
12/14/2005CN1231487C Metallocenes and catalysts for olefin-polymerisation
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231431C Process for preparing substituted 2-3-dihydro-1-indanones
12/08/2005WO2005116198A2 Methods of 1,3-enyne preparation using copper (i) catalysts
12/08/2005WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof
12/08/2005WO2005097100A3 Antibacterial agents
12/08/2005WO2005082350A8 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation